title: First IL-6-blocking drug nears approval for rare blood disorder.
authors.forename: Sarah C P
authors.initials: SC
authors.lastname: Williams
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D005871:Castleman Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D000093242:Interleukin-6 Inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D000093242:Interleukin-6 Inhibitors; C504234:siltuximab